SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma - Quaterly Results

23 Jan 2023 Evaluate
Net sales declined -12.92%  to  Rs. 9258.99 million from Rs. 10633.25 millions.The Net Profit of the company registered a slight decline of -16.77% to Rs. 2275.36  millions from Rs. 2733.84 millions.The company reported a degrowth in operating Profit to 3454.67 millions from 3949.35 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 9258.99 10633.25 -12.92 28311.06 32976.94 -14.15 44007.08 34628.76 27.08
Other Income 615.09 456.69 34.68 2015.25 1587.06 26.98 2239.40 1347.76 66.16
PBIDT 3454.67 3949.35 -12.53 10509.21 13209.14 -20.44 17345.79 14370.43 20.70
Interest 26.16 11.83 121.13 52.33 32.08 63.12 52.40 34.11 53.62
PBDT 3428.51 3937.52 -12.93 10456.88 13177.06 -20.64 17293.39 14336.32 20.63
Depreciation 376.11 278.34 35.13 1091.94 792.21 37.83 1102.96 987.80 11.66
PBT 3052.40 3659.18 -16.58 9364.94 12384.85 -24.38 16190.43 13348.52 21.29
TAX 777.04 925.34 -16.03 2398.74 3123.06 -23.19 4068.88 3378.47 20.44
Deferred Tax 16.20 5.02 222.71 76.99 46.85 64.33 140.08 1.20 11573.33
PAT 2275.36 2733.84 -16.77 6966.20 9261.79 -24.79 12121.55 9970.05 21.58
Equity 164.69 164.30 0.24 164.69 164.30 0.24 164.30 163.59 0.43
PBIDTM(%) 37.31 37.14 0.46 37.12 40.06 -7.33 39.42 41.50 -5.02

Gland Pharma Share Price

1795.80 59.80 (3.44%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×